[LXRX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
25-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 4.51%
YoY- -57.10%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 1,647 1,130 702 162 317 24 28 1416.24%
PBT -53,429 -48,397 -48,244 -50,525 -44,904 -31,934 -30,494 45.38%
Tax 0 101 -2,977 2,854 1,152 -1,029 216 -
NP -53,429 -48,397 -48,244 -50,525 -44,904 -30,905 -30,710 44.70%
Tax Rate - - - - - - - -
Total Cost 55,076 49,527 48,946 50,687 45,221 30,929 30,738 47.57%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -3,244.02 -4,282.92 -6,872.36 -31,188.27 -14,165.30 -128,770.83 -109,678.57 -90.45%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.17 -0.20 -0.20 -0.21 -0.22 -0.16 -0.16 4.12%
EPS Diluted -0.17 -0.20 -0.20 -0.21 -0.22 -0.16 -0.16 4.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.